BRIEF published on 05/23/2025 at 09:10, 1 year 2 months ago BioNxt Solutions s'apprête à obtenir un brevet européen pour son système d'administration de médicaments Sclérose En Plaques Développement De Médicaments Solutions BioNxt Brevet Européen Administration Sublinguale
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Positive Outlook for NFON AG with Strategic Growth Initiatives Growth Strategy NFON AG Recurring Revenue Q1 Sales AI Initiatives
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Perspectives positives pour NFON AG avec des initiatives de croissance stratégique NFON AG Revenus Récurrents Stratégie De Croissance Ventes Du Premier Trimestre Initiatives En Matière D'IA
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Brödernas Group AB Postpones Annual Financial Statement Release Restructuring Process Financial Statement Delay Brödernas Group AB Richard Forsshéll Bonds Default
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Brödernas Group AB reporte la publication de ses états financiers annuels Groupe Brödernas AB Richard Forsshéll Processus De Restructuration Défaut De Paiement Des Obligations Retard Des États Financiers
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Alzchem Group AG Finalizes Succession Planning with New COO Appointment Chief Operating Officer Succession Planning Alzchem Group AG Specialty Chemicals Dr. Jürgen Sans
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Alzchem Group AG finalise sa planification de succession avec la nomination d'un nouveau directeur de l'exploitation Planification De La Relève Chef De L'exploitation Groupe Alzchem AG Produits Chimiques De Spécialité Dr Jürgen Sans
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Secarna Pharmaceuticals Unveils Promising SECN-15 Data at ASCO 2025 Cancer Therapy Clinical Trial Secarna Pharmaceuticals Antisense Oligonucleotide SECN-15
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Secarna Pharmaceuticals dévoile des données prometteuses sur le SECN-15 à l'ASCO 2025 Essai Clinique Secarna Pharmaceuticals Thérapie Contre Le Cancer Oligonucléotide Antisens SECN-15
BRIEF published on 05/23/2025 at 09:03, 1 year 2 months ago Grand City Properties Announces 2025 AGM Details Annual General Meeting Shareholders Real Estate Investment Luxembourg
Published on 08/01/2026 at 01:58, 2 days 15 hours ago Clôture de l'option sur la propriété de graphite au Québec
Published on 08/01/2026 at 01:20, 2 days 15 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 15 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 16 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/03/2026 at 16:45, 23 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights, Issue of Shares and Treasury Shares
Published on 08/03/2026 at 16:45, 23 minutes ago Thailand - Canada Pilot Carbon Capture in Cement Industry to Advance Net Zero 2050
Published on 08/03/2026 at 16:38, 30 minutes ago BVB Japan Tour 2026: Record Reach, 70,000 Fan Contacts and Strong Commercial Momentum
Published on 08/03/2026 at 16:00, 1 hour 8 minutes ago Shares Admitted to Trading and Total Voting Rights
Published on 08/03/2026 at 15:46, 1 hour 21 minutes ago Juillet 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 08/03/2026 at 10:58, 6 hours 10 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from July 27 to July 31 2026
Published on 08/03/2026 at 10:58, 6 hours 10 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 27 au 31 juillet 2026
Published on 08/03/2026 at 10:27, 6 hours 41 minutes ago 2600803 BENETEAU Transactions sur actions propres
Published on 08/03/2026 at 09:56, 7 hours 12 minutes ago Mersen : Rapport financier semestriel 2026_attestation-responsable-corrigée
